National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

sodium phenylbutyrate
The sodium salt of phenylbutyrate, a derivative of the short-chain fatty acid butyrate, with potential antineoplastic activity. Phenylbutyrate reversibly inhibits class I and II histone deacetylases (HDACs), which may result in a global increase in gene expression, decreased cellular proliferation, increased cell differentiation, and the induction of apoptosis in susceptible tumor cell populations. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:sodium 4-phenylbutyrate
US brand name:Buphenyl



Previous:sodium dichloroacetate, sodium ferric gluconate complex in sucrose, sodium fluoride, sodium glycididazole, sodium hyaluronate topical hydrogel
Next:sodium salicylate, sodium stibogluconate, sodium thiosulfate, Sodothiol, Solaraze

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov